BlinkLab (ASX:BB1) Signs Partnership with European INTER-PSY for Clinical Trial, Supporting US and EU Regulatory Approval and Future Market Adoption
By API User
Sydney, Australia – 12 September 2024 | BlinkLab Limited (ASX: BB1) (“BlinkLab” or “the Company”), an innovative digital healthcare company developing AI-powered sensory assessments on smartphones for detecting neurodevelopmental conditions, is pleased to announce a partnership with INTER-PSY in the Netherlands. The new partnership will facilitate a prospective clinical trial for the early diagnosis of … Continued